Analyst Ratings For Innovaderma PLC (LON:IDP)
Today, FinnCap reiterated its Corporate rating on Innovaderma PLC (LON:IDP).
There are 0 Strong Buy Ratings, no Sell Ratings, no Hold Ratings, no Buy Ratings on the stock.
The current consensus rating on Innovaderma PLC (LON:IDP) is N/A with a consensus target price of N/A per share, a potential .
Some recent analyst ratings include
- 2/21/2019-Innovaderma PLC (LON:IDP) had its Corporate rating reiterated by FinnCap
About Innovaderma PLC (LON:IDP)
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, Europe, the United States, Australasia, North Asia, and Africa. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and shampoos, conditioners, and laser technology treatments to treat male and female hair loss, alopecia, and thinning hair under the Leimo brand name. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; cosmetics, such as lipsticks and eyeshadows under the Stevie K brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; and haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name. The company sells its products through online DTC channel, and international retail and distribution partners. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Recent Trading Activity for Innovaderma PLC (LON:IDP)
Shares of Innovaderma PLC closed the previous trading session at 86,90 up +2,40 2,84 % with shares trading hands.